SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
positive
negative
Dec, 11, 2022
$BIVI Biovie Pharmaceuticals $BIVI passes Zacks Equity Research's strict "Recent Price Strength screen", and comes out with glowing colors--and a prediction of further momentum for the stock in near term.
positive
negative
Nov, 10, 2022
The total return on equity for ten years is 117.49%.
Nov, 2, 2022
overall his speech was positive on equity.